AMLX (Amylyx Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) is a publicly traded Healthcare sector company. As of May 21, 2026, AMLX trades at $13.58 with a market cap of $1.43B and a P/E ratio of -8.66. AMLX moved +6.83% today. Year to date, AMLX is +19.49%; over the trailing twelve months it is +146.56%. Its 52-week range spans $2.60 to $18.61. Analyst consensus is strong buy with an average price target of $24.57. Rallies surfaces AMLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading AMLX stock inside the company?
Recent AMLX insider activity includes Klee Justin B. sold 29.28K, Cohen Joshua B sold 29.28K, Bedrosian Camille L sold 6.46K, FRATES JAMES M sold 7.91K, and Mazzariello Gina sold 6.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
AMLX Key Metrics
Key financial metrics for AMLX
Metric
Value
Price
$13.58
Market Cap
$1.43B
P/E Ratio
-8.66
EPS
$-1.53
Dividend Yield
0.42%
52-Week High
$18.61
52-Week Low
$2.60
Volume
333
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-144.74M
Gross Margin
0.00%
Recent AMLX Insider Trades
Klee Justin B. sold 29.28K (~$423.76K) on Mar 2, 2026.
Cohen Joshua B sold 29.28K (~$424.12K) on Mar 2, 2026.
Bedrosian Camille L sold 6.46K (~$94.21K) on Mar 2, 2026.
FRATES JAMES M sold 7.91K (~$114.85K) on Mar 2, 2026.
Mazzariello Gina sold 6.84K (~$99.38K) on Mar 2, 2026.
Recent AMLX insider activity includes Klee Justin B. sold 29.28K, Cohen Joshua B sold 29.28K, Bedrosian Camille L sold 6.46K, FRATES JAMES M sold 7.91K, and Mazzariello Gina sold 6.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for AMLX?
Yes. Rallies tracks AMLX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is AMLX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AMLX. It does not provide personalized investment advice.